90+ lawsuits allege GLP-1 drugs cause rare vision loss condition

Over 90 lawsuits have been filed against manufacturers of GLP-1 diabetes and weight-loss drugs, alleging the medications caused a rare eye condition leading to vision loss. The claims are emerging as a new legal risk for a high-value drug class, though causation is not yet established in court. The outcome could affect pharmaceutical liability and prescribing patterns.